Drugs Made In America Acquisition Corp. has announced that Glenn Worman has resigned as Chief Financial Officer, effective October 8, 2025. Saleem Elmasri has been appointed as the new Chief Financial Officer and principal financial and accounting officer, with his appointment effective November 17, 2025. Mr. Elmasri is a CPA with 20 years of experience in financial and management consulting, including work at PricewaterhouseCoopers and various advisory roles in the life sciences and pharmaceutical industry.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made In America Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-111704), on November 18, 2025, and is solely responsible for the information contained therein.